Medindia

X

Pharmaceutical Industry Veteran Mike Wokasch Publishes New Book, Pharmaplasia(TM), About Why Drug Companies Must Change to Survive Healthcare Reform

Wednesday, July 28, 2010 Drug News J E 4
Advertisement


MCFARLAND, Wis., July 28 Pharmaplasia, a 180-page book, describes how pharmaceutical companies grew too fast, creating organizations that were too large to manage effectively and efficiently given the complexities of the business in an increasingly challenging healthcare market. A revealing insider's perspective with a mix of history, case studies, and definitive recommendations for change make Pharmaplasia an informative and thought-provoking read for past and present industry executives, healthcare providers, and patients alike.

"... Pharmaplasia is important reading for anyone with a vested interest in the pharmaceutical industry (especially those who work in it). In the context of the recently passed healthcare legislation, this book is particularly relevant." -- ForeWord Clarion Reviews (4 out of 5 stars)

Unlike many books written about the pharmaceutical industry, Pharmaplasia is not an expose but rather an insightful dissertation of what's wrong in the pharmaceutical industry, how it got that way, and what companies can do to change for the better. It is an interesting read for those who won't settle for excuses but rather look for straight answers as to why their drugs cost so much, why patients don't have the drugs they might need, and what to reasonably expect from this complex industry in a fast-changing healthcare marketplace.

As in his blog (http://www.PharmaReform.com), the author advocates society's need for a financially healthy pharmaceutical industry but identifies specific actions pharmaceutical companies must take if they intend to remain prosperous in an increasingly demanding and less tolerant healthcare market soon to be further complicated by healthcare reform. He provides a patient-oriented, market-friendly vision for a future pharmaceutical industry that once again puts patients before profits - which helps to reestablish trust and credibility while delivering innovative products at reasonable prices.

The author has more information about Pharmaplasia and has the Table of Contents and Chapter 1 available to preview at http://www.Pharmaplasia.com.

About the Author:

Michael G. Wokasch worked in a retail pharmacy while attending the University of Minnesota College of Pharmacy. Following graduation in 1978, he enlisted in the U.S. Public Health Service as a pharmacist and commissioned officer. He joined Merck & Co. Inc. in 1979 as a pharmaceutical sales representative where he held a number of sales and marketing positions at that company. In 1986 Mr. Wokasch joined Miles Pharmaceuticals where he helped launch the highly successful antibiotic CiproŪ (ciprofloxacin) in the U.S. Mr. Wokasch has held senior management and C-level positions at large and small pharmaceutical and biotechnology companies. He is an engaging and inspirational guest speaker, an industry consultant, and writes a blog about industry reform (http://www.PharmaReform.com). More information about the author and Pharmaplasia can be found at http://www.Pharmaplasia.com.

Author photo: http://www.ereleases.com/pic/Mike-Wokasch.jpg

Book cover: http://www.ereleases.com/pic/Pharmaplasia.jpg

This press release was issued through eReleases(R). For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

CONTACT: Mike Wokasch Wokasch Consulting, LLC 5420 Bremer Road McFarland, WI 53558 608-838-3237 mgw6@sbcglobal.net

SOURCE Wokasch Consulting, LLC
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Alere Inc. Announces Second Quarter 2010 Results
S
HemaQuest Pharmaceuticals Raises Additional $4M to...